Marika Ruponen
Impact in
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
- Ophthalmology top 1%
- Retinal Diseases and Treatments
Papers in
-
- RNA Interference and Gene Delivery 25
- Retinal Development and Disorders 14
- Advanced biosensing and bioanalysis techniques 12
-
- Retinal Diseases and Treatments 15
- Glaucoma and retinal disorders 9
- Co-authors
- Arto Urtti (58 shared papers)Seppo Ylä‐Herttuala (5 shared papers)Eva M. del Amo (14 shared papers)Paavo Honkakoski (4 shared papers)Markku Tammi (3 shared papers)Elisa Toropainen (24 shared papers)Seppo Rönkkö (4 shared papers)Kati‐Sisko Vellonen (17 shared papers)
In The Last Decade
Marika Ruponen
92 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 107
- Pharmaceutical Science 609
- Ophthalmology 399
- Molecular Biology 2.0k
- Biomaterials 343
- Genetics 573
Countries citing papers authored by Marika Ruponen
This map shows the geographic impact of Marika Ruponen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marika Ruponen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marika Ruponen more than expected).
Fields of papers citing papers by Marika Ruponen
This network shows the impact of papers produced by Marika Ruponen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marika Ruponen. The network helps show where Marika Ruponen may publish in the future.
Co-authors
The 25 scholars most cited alongside Marika Ruponen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 311 | |
| 2 | 2002 | 201 | |
| 3 | 2019 | 190 | |
| 4 | 2001 | 190 | |
| 5 | 2003 | 136 | |
| 6 | 1999 | 129 | |
| 7 | 2018 | 115 | |
| 8 | 2004 | 99 | |
| 9 | 2020 | 89 | |
| 10 | 2015 | 88 | |
| 11 | 2019 | 76 | |
| 12 | 2016 | 72 | |
| 13 | 2007 | 60 | |
| 14 | 2018 | 59 | |
| 15 | 2013 | 58 | |
| 16 | 2004 | 53 | |
| 17 | 2021 | 52 | |
| 18 | 2017 | 50 | |
| 19 | 2017 | 50 | |
| 20 | 2003 | 44 |
About Marika Ruponen
Marika Ruponen is a scholar working on Molecular Biology, Ophthalmology, Pharmaceutical Science, Public Health, Environmental and Occupational Health and Genetics, having authored 96 papers that have together received 3.4k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (25 papers), Advanced Drug Delivery Systems (17 papers), Retinal Diseases and Treatments (15 papers), Retinal Development and Disorders (14 papers), Ocular Surface and Contact Lens (12 papers), Advanced biosensing and bioanalysis techniques (12 papers), Virus-based gene therapy research (11 papers) and Glaucoma and retinal disorders (9 papers). The work is most often cited by research in Pharmaceutical Science (609 citations), Ophthalmology (399 citations), Molecular Biology (2.0k citations), Biomaterials (343 citations) and Genetics (573 citations). Marika Ruponen has collaborated with scholars based in Finland, Russia and Italy. Frequent co-authors include Arto Urtti, Seppo Ylä‐Herttuala, Eva M. del Amo, Paavo Honkakoski, Markku Tammi, Elisa Toropainen, Seppo Rönkkö, Kati‐Sisko Vellonen, Veli‐Pekka Ranta and Jukka Pelkonen. Their work appears in journals such as European Journal of Pharmaceutical Sciences, Pharmaceutics, Journal of Controlled Release, European Journal of Pharmaceutics and Biopharmaceutics and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.